BBeyond News Search Beyond News…

Loading…

JNJ

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.

Recent news mentioning JNJ

2026-08-10 — Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
2026-08-08 — Why PG, JNJ, and KO Could Surprise Investors Next Year
2026-08-04 — The $85 Billion Consolation Prize For JNJ Shareholders
2026-08-03 — Jim Cramer Analyzes Johnson & Johnson (JNJ) After Surgical Robotics Milestone
2026-07-27 — Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings?
2026-07-27 — President Trump Loves Johnson & Johnson (JNJ), But Insiders Are Selling
2026-07-25 — Jim Cramer Said To Buy Johnson & Johnson (NYSE:JNJ)’s Shares – Here’s What Happened Next
2026-07-23 — J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.
2026-07-20 — Reading Between The Lines Of JNJ Stock's Latest Call
2026-07-13 — JNJ Vs. KO: Which Dividend Stock Is The Better Buy?
2026-07-13 — The Real Case for Buying Johnson & Johnson (JNJ) Before July 15
2026-07-07 — Unusual Put Option Activity in Johnson & Johnson After JNJ Stock's Recent Runup

Appears alongside

See JNJ's full profile, network and analytical read on Beyond →